The challenges of developing and commercializing biosimilars in Latin America

Pharm Pat Anal. 2019 Nov;8(6):221-224. doi: 10.4155/ppa-2019-0026. Epub 2020 Jan 3.
No abstract available

Keywords: Latin America; biosimilars; intended copies.

Publication types

  • Editorial

MeSH terms

  • Biosimilar Pharmaceuticals*
  • Drug Development*
  • Drug Industry
  • Latin America
  • Rituximab

Substances

  • Biosimilar Pharmaceuticals
  • Rituximab